Drug intelligence / Profile preview

Technetium Tc-99m ciprofloxacin

Development stage
Preclinical
Lead developer
Jubilant DraxImage
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium Tc-99m ciprofloxacin is a radiopharmaceutical agent that combines the fluoroquinolone antibiotic ciprofloxacin with the radioisotope technetium Tc-99m. It is primarily investigated as a diagnostic imaging agent for detecting sites of bacterial infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis, and tuberculosis. The mechanism involves the antibiotic portion binding to bacterial DNA gyrase—an enzyme essential for DNA supercoiling in bacteria—while the attached Tc-99m enables visualization via nuclear medical imaging techniques such as SPECT. There remains some controversy regarding its specificity in distinguishing between sterile inflammation and true bacterial infection[1][2][4][6][8].

Brand names
Infecton
Other names
technetium tc-99m ciprofloxacin
02

Targets

Nonspecific bacterial surface and cell-wall componentsDNA gyrase

Beyond the preview

Go deeper on Technetium Tc-99m ciprofloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Technetium Tc-99m ciprofloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call